Physician's Therapeutics Drug Alert Archives – April 1, 2000
April 1, 2000
View Issues
-
FDA Removes Rezulin From the U.S. Market
-
Alosetron Tablets (Lotronex — Glaxo Wellcome)
-
Gatifloxacin Tablets and Injection (Tequin, Bristol-Myers Squibb)
-
Effects of ACE Inhibition on Cardiovascular Events in High-Risk Patients
-
Can tPA be Used Safely for Acute Ischemic Stroke in Your Emergency Room?
-
Amoxicillin/Clavulanate is More Effective than Azithromycin in Eradicating Pediatric Ear Infections